Iqvia Holdings Inc (IQV) Stock Price, Quote & News

Company Profile

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 919 998 2000

Website: www.iqvia.com

Address:

2400 Ellis Road, Durham, United States

Tenet_Trading Jul. 29 at 7:33 PM

$IQV slept on ticket

0 · Reply

topstockalerts Jul. 28 at 8:07 PM

$IQV that breakout actually stuck

0 · Reply

AcceleratorModel Jul. 28 at 5:22 PM

$IQV nice

0 · Reply

HundredXQuest Jul. 28 at 4:34 PM

$IQV Hearing whispers that OZSC is bringing in a seasoned VP of International Sales to lead global expansion for their subsidiary lines. Dedicated sales leadership is going to transform the revenue baseline! 🔥🚀

0 · Reply

Trading_up_portfolio Jul. 28 at 4:19 PM

Made a bunch of changes to my portfolio today: - Closed the last of my $GOOG position from last year, rolling into LEAPS - closed out of $FIG Options for 50%. Still have shares and will add on dips. - closed $IQV position off of ER beat - decided to keep $OKLO the risk reward is worth - added $AMD for earnings 🪶🪶🪶

0 · Reply

EarningsInsider Jul. 28 at 2:15 PM

https://www.marketbeat.com/earnings/reports/2026-7-28-iqvia-holdings-inc-stock/ $IQV IQVIA Earnings Transcript

0 · Reply

Trading_up_portfolio Jul. 28 at 2:09 PM

$IQV I unfortunately had to exit this position with, great gains

0 · Reply

flychicken1991 Jul. 28 at 1:39 PM

$IQV Positive (84%): shares face upward price pressure because the reported beat and guidance increase imply that current revenue, earnings, and cash-flow expectations are too low. Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/55f9dd646dbc05aa?utm_source=stocktwits&utm_medium=story_url

0 · Reply

OpenOutcrier Jul. 28 at 1:09 PM

$IQV (+10.2% pre) IQV: Revenue and earnings grew strongly in Q2 2026, prompting raised full-year guidance https://ooc.bz/l/108842

0 · Reply

StocktwitsEarnings Jul. 28 at 11:08 AM

$IQV Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $1.54 down -0.65% YoY • Reported revenue of $4.37B up 8.74% YoY • IQVIA Holdings Inc. is raising its full-year 2026 guidance for revenue to between $17,275 million and $17,475 million, Adjusted EBITDA to $4,000-$4,050 million, and Adjusted Diluted EPS to $12.80-$13.00.

0 · Reply

Iqvia price target raised to $247 from $221 at RBC Capital

2026-07-29T13:25:25.000Z - 16 hours ago

Iqvia price target raised to $288 from $233 at TD Cowen

2026-07-29T13:20:52.000Z - 16 hours ago

Iqvia price target raised to $280 from $245 at BofA

2026-07-29T12:10:19.000Z - 18 hours ago

Iqvia price target raised to $270 from $210 at BMO Capital

2026-07-29T12:03:53.000Z - 18 hours ago

Iqvia price target raised to $285 from $225 at JPMorgan

2026-07-29T11:01:00.000Z - 19 hours ago

Iqvia price target raised to $276 from $220 at Stifel

2026-07-29T10:45:37.000Z - 19 hours ago

Iqvia price target raised to $287 from $252 at Baird

2026-07-28T19:35:16.000Z - 1 day ago

Iqvia price target raised to $240 from $200 at Morgan Stanley

2026-07-28T19:10:17.000Z - 1 day ago

Iqvia price target raised to $275 from $210 at Barclays

Jul 28, 2026, 12:44 PM EDT - 1 day ago

This Healthcare Stock Is Today's Best in the S&P 500

Jul 28, 2026, 9:02 AM EDT - 1 day ago

IQVIA raises annual profit forecast on clinical research demand

Jul 28, 2026, 9:00 AM EDT - 1 day ago

IQVIA Holdings Earnings Call Transcript: Q2 2026

Jul 28, 2026, 9:00 AM EDT - 1 day ago

IQVIA Holdings Earnings release: Q2 2026

Jul 28, 2026, 9:00 AM EDT - 1 day ago

IQVIA Holdings Slides: Q2 2026

Jul 28, 2026, 9:00 AM EDT - 1 day ago

IQVIA Holdings Quarterly report: Q2 2026

2026-07-28T11:10:23.000Z - 1 day ago

Iqvia reports Q2 EPS $3.15, consensus $3.03

Jul 28, 2026, 7:00 AM EDT - 1 day ago

IQVIA Reports Second-Quarter 2026 Results

Jul 16, 2026, 1:39 PM EDT - 13 days ago

IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States

2026-07-13T11:45:21.000Z - 16 days ago

Iqvia price target raised to $230 from $215 at Mizuho

2026-07-09T12:35:26.000Z - 20 days ago

Iqvia named short-term buy idea at Deutsche Bank

Jul 8, 2026, 4:15 PM EDT - 21 days ago

IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026

2026-07-06T14:25:38.000Z - 23 days ago

Iqvia price target raised to $240 from $210 at HSBC

2026-07-01T10:35:37.000Z - 4 weeks ago

Iqvia price target raised to $249 from $230 at Baird

Jun 18, 2026, 10:17 AM EDT - 5 weeks ago

StackAdapt Teams Up with IQVIA Digital's MediaOS to Power Healthcare Advertising

Jun 17, 2026, 12:30 PM EDT - 6 weeks ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX

2026-06-17T10:36:54.000Z - 6 weeks ago

Iqvia downgraded to Equal Weight from Overweight at Morgan Stanley

CRL

Jun 15, 2026, 9:00 AM EDT - 6 weeks ago

Wiley and IQVIA Release Cross-Sector Report on AI's Promise and Pressure Points Across Healthcare Value Chain

WLY

Jun 4, 2026, 10:51 AM EDT - 7 weeks ago

IQVIA Announces Pricing of Senior Notes

Jun 3, 2026, 9:20 AM EDT - 2 months ago

IQVIA Holdings Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:53 AM EDT - 2 months ago

IQVIA Announces Offering of Senior Notes

May 26, 2026, 4:15 PM EDT - 2 months ago

IQVIA CEO to Speak at Jefferies Global Healthcare Conference

May 13, 2026, 4:30 PM EDT - 2 months ago

IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities

May 13, 2026, 1:40 PM EDT - 2 months ago

IQVIA Holdings Transcript: Bank of America Global Healthcare Conference 2026

May 7, 2026, 5:15 PM EDT - 2 months ago

IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization

May 6, 2026, 4:15 PM EDT - 3 months ago

IQVIA CFO to Speak at Bank of America Health Care Conference 2026

May 5, 2026, 9:00 AM EDT - 3 months ago

IQVIA Holdings Earnings Call Transcript: Q1 2026

May 5, 2026, 9:00 AM EDT - 3 months ago

IQVIA Holdings Earnings release: Q1 2026

May 5, 2026, 9:00 AM EDT - 3 months ago

IQVIA Holdings Slides: Q1 2026

May 5, 2026, 9:00 AM EDT - 3 months ago

IQVIA Holdings Quarterly report: Q1 2026

May 5, 2026, 7:00 AM EDT - 3 months ago

IQVIA Reports First-Quarter 2026 Results

Apr 15, 2026, 4:15 PM EDT - 3 months ago

IQVIA to Announce First-Quarter 2026 Results on May 5, 2026

Mar 16, 2026, 4:30 PM EDT - 4 months ago

IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences

Mar 12, 2026, 9:30 AM EDT - 4 months ago

IQVIA Holdings Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 9, 2026, 9:20 AM EDT - 5 months ago

IQVIA Holdings Transcript: Leerink Global Healthcare Conference 2026

Mar 2, 2026, 4:30 PM EST - 5 months ago

IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference

Mar 2, 2026, 4:15 PM EST - 5 months ago

IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference

Feb 27, 2026, 4:47 PM EST - 5 months ago

IQVIA Releases its 2025 Sustainability Report

Feb 27, 2026, 7:00 AM EST - 5 months ago

IQVIA Holdings Proxy statement: Proxy Filing

Feb 27, 2026, 7:00 AM EST - 5 months ago

IQVIA Holdings Proxy statement: Proxy Filing

Feb 26, 2026, 11:00 AM EST - 5 months ago

IQVIA Holdings Transcript: Citi’s 2026 Unplugged MedTech and Life Sciences Access Day

Feb 25, 2026, 7:00 AM EST - 5 months ago

IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities

Feb 24, 2026, 9:01 AM EST - 5 months ago

10 stocks Wall Street expects to roar back after dropping at least 20% in 2026

APP BKNG COF CSGP KKR NOW ORCL

Feb 18, 2026, 4:15 PM EST - 5 months ago

IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day

Feb 10, 2026, 8:00 AM EST - 6 months ago

IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions

Feb 5, 2026, 9:07 AM EST - 6 months ago

IQVIA forecasts weak annual profit on higher interest expenses

Feb 5, 2026, 9:00 AM EST - 6 months ago

IQVIA Holdings Earnings Call Transcript: Q4 2025

Feb 5, 2026, 9:00 AM EST - 6 months ago

IQVIA Holdings Annual report: Q4 2025

Feb 5, 2026, 9:00 AM EST - 6 months ago

IQVIA Holdings Earnings release: Q4 2025

Feb 5, 2026, 9:00 AM EST - 6 months ago

IQVIA Holdings Slides: Q4 2025

Feb 5, 2026, 7:00 AM EST - 6 months ago

IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

Jan 29, 2026, 8:00 AM EST - 6 months ago

IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration

Jan 22, 2026, 4:05 PM EST - 6 months ago

IQVIA Named to the Fortune® World's Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year

Jan 20, 2026, 4:45 PM EST - 6 months ago

IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026

Dec 2, 2025, 8:00 AM EST - 8 months ago

IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform

Nov 11, 2025, 12:30 PM EST - 9 months ago

IQVIA Holdings Transcript: UBS Global Healthcare Conference 2025

Nov 5, 2025, 4:15 PM EST - 9 months ago

Dr. William G. Kaelin Jr. joins IQVIA Board of Directors

Oct 28, 2025, 9:00 AM EDT - 9 months ago

IQVIA Holdings Earnings Call Transcript: Q3 2025

Oct 28, 2025, 9:00 AM EDT - 9 months ago

IQVIA Holdings Quarterly report: Q3 2025

Oct 28, 2025, 9:00 AM EDT - 9 months ago

IQVIA Holdings Earnings release: Q3 2025

Oct 28, 2025, 9:00 AM EDT - 9 months ago

IQVIA Holdings Slides: Q3 2025

Oct 28, 2025, 7:53 AM EDT - 9 months ago

IQVIA narrows annual profit forecast amid continued research contract cancellations

Oct 28, 2025, 7:00 AM EDT - 9 months ago

IQVIA Reports Third-Quarter 2025 Results

Oct 21, 2025, 4:15 PM EDT - 10 months ago

IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025

Sep 30, 2025, 4:15 PM EDT - 10 months ago

IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025

Sep 26, 2025, 9:40 AM EDT - 10 months ago

ILMN Stock vs. IQV Stock

ILMN

Sep 16, 2025, 8:00 AM EDT - 11 months ago

IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships

Sep 10, 2025, 8:00 AM EDT - 11 months ago

IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management

Sep 2, 2025, 9:41 AM EDT - 11 months ago

IQVIA names Michael Fedock as financial chief

Sep 2, 2025, 9:00 AM EDT - 11 months ago

IQVIA Announces CFO Transition in Early 2026

Aug 28, 2025, 8:00 AM EDT - 11 months ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX MRNA SANA

Aug 19, 2025, 12:00 PM EDT - 1 year ago

The Big 3: BLDR, IQV, LOW

BLDR LOW

Aug 18, 2025, 9:00 AM EDT - 1 year ago

IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes

VEEV

Jul 22, 2025, 9:00 AM EDT - 1 year ago

IQVIA Holdings Earnings Call Transcript: Q2 2025

Jul 22, 2025, 9:00 AM EDT - 1 year ago

IQVIA Holdings Quarterly report: Q2 2025

Jul 22, 2025, 9:00 AM EDT - 1 year ago

IQVIA Holdings Earnings release: Q2 2025

Jul 22, 2025, 9:00 AM EDT - 1 year ago

IQVIA Holdings Slides: Q2 2025

Jul 22, 2025, 8:42 AM EDT - 1 year ago

IQVIA beats quarterly estimates on resilient demand for healthcare analytics

Jul 22, 2025, 7:00 AM EDT - 1 year ago

IQVIA Reports Second-Quarter 2025 Results

Jul 1, 2025, 7:00 AM EDT - 1 year ago

IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025

Jun 16, 2025, 9:00 AM EDT - 1 year ago

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement'

Jun 11, 2025, 7:00 AM EDT - 1 year ago

IQVIA Launches New AI Agents for Life Sciences and Healthcare

May 27, 2025, 7:00 AM EDT - 1 year ago

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

RNTX

May 16, 2025, 8:00 AM EDT - 1 year ago

IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials

Tenet_Trading Jul. 29 at 7:33 PM

$IQV slept on ticket

0 · Reply

topstockalerts Jul. 28 at 8:07 PM

$IQV that breakout actually stuck

0 · Reply

AcceleratorModel Jul. 28 at 5:22 PM

$IQV nice

0 · Reply

HundredXQuest Jul. 28 at 4:34 PM

0 · Reply

Trading_up_portfolio Jul. 28 at 4:19 PM

0 · Reply

EarningsInsider Jul. 28 at 2:15 PM

https://www.marketbeat.com/earnings/reports/2026-7-28-iqvia-holdings-inc-stock/ $IQV IQVIA Earnings Transcript

0 · Reply

Trading_up_portfolio Jul. 28 at 2:09 PM

$IQV I unfortunately had to exit this position with, great gains

0 · Reply

flychicken1991 Jul. 28 at 1:39 PM

0 · Reply

OpenOutcrier Jul. 28 at 1:09 PM

$IQV (+10.2% pre) IQV: Revenue and earnings grew strongly in Q2 2026, prompting raised full-year guidance https://ooc.bz/l/108842

0 · Reply

StocktwitsEarnings Jul. 28 at 11:08 AM

0 · Reply

JodieChristy Jul. 21 at 3:36 PM

Institutional activity alert! $IQV sees $2M+ Call flow as smart money watches key support! Life sciences leader IQVIA ($IQV) trades at $201.45, down -1.23%, while absorbing short-term selling pressure around key horizontal demand levels. A notable options flow signal emerged with $2M+ in IQV Call activity, suggesting potential institutional positioning. The key now is whether buyers continue defending this support zone. Every move has a reason. Follow the clues. A confirmed breakout above resistance could trigger the next momentum expansion.

0 · Reply

Antwan61186 Jul. 6 at 12:52 PM

$IQV timbbbeeerrrrrr

0 · Reply

SuperGreenToday Jul. 2 at 1:19 PM

$IQV Share Price: $203.29 Contract Selected: Jan 15, 2027 $200 Calls Buy Zone: $22.22 – $27.44 Target Zone: $36.00 – $44.00 Potential Upside: 53% ROI Time to Expiration: 196 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

BillionerOfKing Jun. 23 at 10:55 PM

$IQV Current Stock Price: $171.22 Contracts to trade: $170.0 IQV Jul 17 2026 Call Entry: $7.60 Exit: $13.52 ROI: 78% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

SuperGreenToday Jun. 23 at 6:56 AM

$IQV Share Price: $167.83 Contract Selected: Jan 15, 2027 $170 Calls Buy Zone: $25.86 – $31.94 Target Zone: $48.01 – $58.68 Potential Upside: 75% ROI Time to Expiration: 206 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

ripster47 Jun. 17 at 2:49 PM

$IQV | Morgan Stanley Downgrades IQVIA Holdings to Equalweight with $200 PT on AI Monetization Uncertainty Morgan Stanley stays cautious as limited near-term upside and AI-related overhang temper multiple expansion. 🔹 Follow @tenet_research for more analyst insights on other tickers.

0 · Reply

briefingcom Jun. 17 at 12:45 PM

$IQV: IQVIA downgraded to Equal Weight from Overweight at Morgan Stanley, tgt $200 https://www.briefing.com/calendars/updown?Filter=downgrades&utm_campaign=updown&utm_medium=social&utm_source=st&utm_content=link

0 · Reply

SuperGreenToday Jun. 3 at 7:26 AM

$IQV Share Price: $180.62 Contract Selected: Nov 20, 2026 $180 Calls Buy Zone: $16.41 – $20.27 Target Zone: $27.07 – $33.09 Potential Upside: 56% ROI Time to Expiration: 169 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Market Cap	40.55B
Revenue (ttm)	16.31B
Net Income (ttm)	1.36B
EPS (ttm)	N/A
PE Ratio	19.14
Forward PE	18.42
Profit Margin	8.34%
Debt to Equity Ratio	2.49

Volume	2,241,700
Avg Vol	1,615,592
Day's Range	N/A - N/A
Shares Out	166.90M
Stochastic %K	93%
Beta	1.20
Analysts	Strong Sell
Price Target	$228.30